Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Stock Price Up 7.3%

Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report)’s share price rose 7.3% during mid-day trading on Friday . The stock traded as high as C$2.86 and last traded at C$2.81. Approximately 8,322 shares were traded during trading, an increase of 12% from the average daily volume of 7,410 shares. The stock had previously closed at C$2.62.

Eupraxia Pharmaceuticals Stock Performance

The company’s 50-day moving average is C$2.74 and its 200-day moving average is C$3.47.

About Eupraxia Pharmaceuticals

(Get Free Report)

Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company’s lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.

Featured Articles

• Five stocks we like better than Eupraxia Pharmaceuticals
• The Significance of Brokerage Rankings in Stock Selection
• Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
• Investing In Preferred Stock vs. Common Stock
• This Financial Stock’s Earnings Signal a Buying Opportunity
• What is a buyback in stocks? A comprehensive guide for investors
• Social Platform Stock Hits New Highs: Is More Growth Ahead?

Receive News & Ratings for Eupraxia Pharmaceuticals Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com’s FREE daily email newsletter.